HM Payson & Co’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,507,777
Closed -$88.4M 1171
2025
Q3
$88.4M Buy
3,507,777
+388,247
+12% +$9.76M 1.27% 24
2025
Q2
$78.5M Sell
3,119,530
-168,187
-5% -$4.22M 1.24% 26
2025
Q1
$82.7M Buy
3,287,717
+245,510
+8% +$6.16M 1.45% 23
2024
Q4
$76.2M Buy
3,042,207
+280,278
+10% +$7.02M 1.29% 23
2024
Q3
$69.3M Buy
2,761,929
+80,739
+3% +$2.01M 1.19% 27
2024
Q2
$66.7M Buy
2,681,190
+173,859
+7% +$4.31M 1.21% 29
2024
Q1
$62.2M Buy
2,507,331
+383,209
+18% +$9.49M 1.16% 29
2023
Q4
$52.6M Buy
2,124,122
+414,869
+24% +$10.2M 1.09% 28
2023
Q3
$41.7M Buy
1,709,253
+1,595,861
+1,407% +$38.9M 0.98% 30
2023
Q2
$2.76M Buy
+113,392
New +$2.78M 0.06% 126
2022
Q4
Sell
-30,000
Closed -$724K 964
2022
Q3
$724K Buy
+30,000
New +$740K 0.02% 207

Other funds holding IBDQ

HM Payson & Co's IBDQ Position: Q4 2025 in Review

HM Payson & Co sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 3,507,777 shares — an estimated $88.4M sold.

HM Payson & Co first reported a position in IBDQ in Q3 2022 and held it in 11 quarters. The position peaked at $88.4M in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • HM Payson & Co reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • HM Payson & Co sold 3,507,777 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $88.4M.
  • HM Payson & Co first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2022 and held it in 11 quarters.
  • HM Payson & Co's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $88.4M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on HM Payson & Co's 13F filing for Q4 2025, filed 12 Feb 2026.